Physician specialty
Gynecologic Oncology
At a glance
- Practicing in the U.S.
- 1,829
- Per 100,000 residents
- 0.5
- Women
- 53%
- Median years since graduating
- 21
Training path
- College (bachelor’s degree) 4 years
- Medical school (MD or DO) 4 years
- Obstetrics and gynecology residency 4 years
- Gynecologic oncology fellowship 3 years
Training after medical school: 7 years. From the start of college: about 15 years.
Usual minimum program lengths from ACGME program requirements. Some doctors take extra research years or a second fellowship.
Who they are
- MD (DOs make up the rest) 95%
- Women 53%
- Graduated 35 or more years ago 17%
- Offer telehealth 56%
- Accept Medicare’s approved amount 96%
Sex and credentials from NPPES. Graduation year, telehealth and Medicare assignment from Medicare Care Compare, which covers clinicians enrolled in Medicare.
Where they practice
What they do most for Medicare patients
- Established patient office or other outpatient visit, 30-39 minutes 99,262
- Established patient office or other outpatient visit, 20-29 minutes 70,605
- Established patient office or other outpatient visit, 40-54 minutes 44,160
- New patient office or other outpatient visit, 60-74 minutes 23,131
- Insertion of needle into vein for collection of blood sample 18,544
- Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 18,373
- New patient office or other outpatient visit, 45-59 minutes 14,072
- Administration of chemotherapy into vein, 1 hour or less 11,510
- Injection of additional new drug or substance into vein 11,253
- Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 10,434
- Immunologic analysis for detection of tumor antigen, quantitative; ca 125 9,705
- Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less 9,541
Services billed to traditional Medicare in 2023 (Physician and Other Practitioners data); drugs given in the office are left out.
What they prescribe most
- Oxycodone Hcl (Oxycontin, Roxicodone, Roxybond) 7.9%
- Ondansetron Hcl 7.2%
- Estradiol (Divigel, Estring, Estrogel) 6.0%
- Prochlorperazine Maleate 5.8%
- Dexamethasone (Hemady, Maxidex, Ozurdex) 5.8%
- Gabapentin (Gralise, Neurontin) 5.0%
- Letrozole (Femara) 4.4%
- Ibuprofen (Caldolor, Ibu) 4.1%
- Hydrocodone/Acetaminophen (Hydrocodone-Acetaminophen) 4.0%
- Apixaban (Eliquis) 3.3%
- Tramadol Hcl 3.1%
- Olaparib (Lynparza) 2.9%
- Ondansetron 2.9%
- Megestrol Acetate 2.8%
- Oxycodone Hcl/Acetaminophen (Endocet, Oxycodone-Acetaminophen, Percocet) 2.5%
Share of this specialty’s Medicare Part D prescriptions in 2024, including refills. Select a drug to see which of these clinicians prescribe it most, and where.
Hospitals where the most work
- NYU Langone Hospitals New York, NY 17 Gynecologic Oncology at NYU Langone Hospitals
- New York-Presbyterian Hospital New York, NY 14 Gynecologic Oncology at New York-Presbyterian Hospital
- Hospital of Univ of Pennsylvania Philadelphia, PA 13 Gynecologic Oncology at Hospital of Univ of Pennsylvania
- Cleveland Clinic Cleveland, OH 13 Gynecologic Oncology at Cleveland Clinic
- Unc Hospitals Chapel Hill, NC 13 Gynecologic Oncology at Unc Hospitals
- The University of Chicago Medical Center Chicago, IL 12 Gynecologic Oncology at The University of Chicago Medical Center
- University of Colorado Hospital Authority Aurora, CO 12 Gynecologic Oncology at University of Colorado Hospital Authority
- M Health Fairview Southdale Hospital Edina, MN 12 Gynecologic Oncology at M Health Fairview Southdale Hospital
- M Health Fairview University of Mn Medical Center Minneapolis, MN 11 Gynecologic Oncology at M Health Fairview University of Mn Medical Center
- University of Washington Medical Ctr Seattle, WA 11 Gynecologic Oncology at University of Washington Medical Ctr
Clinicians who list the hospital in Medicare Care Compare. The number opens the list of who works there.
Schools they graduated from most
- Northwestern University Feinberg Medical School 20
- University of Alabama School of Medicine 19
- University of Miami, Lm Miller School of Medicine 19
- University of North Carolina at Chapel Hill School of Medicine 19
- Columbia University College of Physicians and Surgeons 17
- Georgetown University School of Medicine 17
- Medical College of Georgia School of Medicine 17
- New York University School of Medicine 16
- University of Southern California Keck School of Medicine 16
- University of Tennessee, Hsc, College of Medicine 16
From Medicare Care Compare (Medicare-enrolled clinicians only).
Industry payments
Drug and device makers reported $7.3M in general payments to 1,178 clinicians in Gynecologic Oncology in 2025. See who received the most
Source: CMS Open Payments, program year 2025. A payment is not evidence of wrongdoing.
Research in this field
U.S. researchers published 53,546 articles and reviews in oncology in 2024–2026.
Journals with the most U.S. papers
- Journal of Clinical Oncology Lippincott Williams & Wilkins 2,249
- Cancers Multidisciplinary Digital Publishing Institute 1,010
- Annals of Oncology Elsevier BV 978
- Cureus Cureus, Inc. 902
- Annals of Surgical Oncology Springer Science+Business Media 863
- Gynecologic Oncology Elsevier BV 737
- International Journal of Radiation Oncology*Biology*Physics Elsevier BV 673
- Laboratory Investigation Elsevier BV 652
- Neuro-Oncology Oxford University Press 615
- Transplantation and Cellular Therapy Elsevier BV 615
Most-cited recent papers
- Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (opens in a new tab) CA A Cancer Journal for Clinicians, 2024 · cited 30,549 times · free to read
- Cancer statistics, 2024 (opens in a new tab) CA A Cancer Journal for Clinicians, 2024 · cited 10,142 times · free to read
- Cancer statistics, 2025 (opens in a new tab) CA A Cancer Journal for Clinicians, 2025 · cited 3,609 times · free to read
- Global patterns and trends in breast cancer incidence and mortality across 185 countries (opens in a new tab) Nature Medicine, 2025 · cited 1,408 times
- Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study (opens in a new tab) The Lancet, 2024 · cited 974 times
- Breast cancer statistics 2024 (opens in a new tab) CA A Cancer Journal for Clinicians, 2024 · cited 905 times · free to read
- The Lancet Commission on prostate cancer: planning for the surge in cases (opens in a new tab) The Lancet, 2024 · cited 827 times · free to read
- Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma (opens in a new tab) New England Journal of Medicine, 2024 · cited 683 times · free to read
From OpenAlex, an open index of research papers. Papers with at least one author at a U.S. institution, classified by subject; the subject covers the whole field, so related specialties share these lists. Citation counts change daily.
Sources: CMS NPPES (counts, sex, credentials), Medicare Care Compare (schools, graduation years, hospitals, telehealth), CMS Medicare Physician & Other Practitioners (2023) and Part D Prescribers (2024), CMS Open Payments (2025), ACGME program requirements (training length), OpenAlex (research), U.S. Census Bureau ACS 2020–2024 (population).